Adverse Drug Reactions in Psychiatry: An Alarming Scenario

Authors

  • Vithanala Srinivasa Rao Department of Pharmacy Practice, Lydia College of Pharmacy, Ravulapalem, Andhra Pradesh, India.
  • Kandula Suresh Kumar Department of Pharmacy Practice, Lydia College of Pharmacy, Ravulapalem, Andhra Pradesh, India.
  • K. Slesha Kumar Department of Pharmacy Practice, Lydia College of Pharmacy, Ravulapalem, Andhra Pradesh, India.
  • G. Santosh Kumar Department of Pharmacy Practice, Lydia College of Pharmacy, Ravulapalem, Andhra Pradesh, India.

DOI:

https://doi.org/10.61427/jcpr.v4.i3.2024.130

Keywords:

Adverse Drug Reactions, Clinical Pharmacist, Psychiatry, Risperidone

Abstract

In the world, India is the largest producer of pharmaceuticals. It is very much essential that the treatment with these drugs should be efficacious, safe and cost effective. Every year, introduction of newer drugs and the production of various pharmaceutical products were increasing. World Health Organization (WHO) realized the need for a responsible surveillance system in order to ban the noxious drugs in the market. Both in hospitalized and ambulatory patients, ADRs are the significant cause of morbidity and mortality. Around 6-15% of the hospitalized patients may experience a serious ADR and nearly 6.5% of the hospital admissions are admission due to ADR. Some of the new ADRs that can be seen with psychotropic drugs are Risperidone associated with an increased risk of stroke in elderly patients with dementia and dopamine receptor agonists (Cabergoline and Pergolide) associated with cardiac valve fibrosis. So many drugs act at more than one receptor type. Tricyclic antidepressants shows their therapeutic effect by the stimulation of monoaminergic pathways by a reduction in monoamine reuptake, but tricyclic antidepressants also show the antimuscaranic activity and this is responsible for adverse effects like retention of urine, drymouth and constipation. To avoid the noxious reactions of psychotropic drugs, pharmacovigilance plays a pivotal role in detecting the adverse drug reactions that alert the psychiatrist in their management. In developing countries like India, pharmacovigilance activities are still in initial stage and especially in case of psychotropic drugs only few reports are available on this concern. A wide range of surveillance programs on adverse drug reactions of psychotropic drugs should be emphasized, in our Indian scenario to strengthen the database.

Downloads

Download data is not yet available.

References

Ryan R, Santesso N, Lowe D, Hill S, Grimshaw J, Prictor M, Kaufman C, Cowie G, Taylor M. Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews. Cochrane Database Syst Rev. 2014 Apr 29; 2014(4): CD007768.

Kar SS, Pradhan HS, Mohanta GP. Concept of essential medicines and rational use in public health. Indian J Community Med. 2010 Jan; 35(1):10-3.

Suke SG, Kosta P, Negi H. Role of Pharmacovigilance in India: An overview. Online J Public Health Inform. 2015 Jul 1; 7(2): e223.

Giardina C, Cutroneo PM, Mocciaro E, Russo GT, Mandraffino G, Basile G, Rapisarda F, Ferrara R, Spina E, Arcoraci V. Adverse Drug Reactions in Hospitalized Patients: Results of the FORWARD (Facilitation of Reporting in Hospital Ward) Study. Front Pharmacol. 2018 Apr 11; 9: 350.

Ramesh M, Pandit J, Parthasarathi G. Adverse drug reactions in a south Indian hospital—their severity and cost involved. Pharmacoepidemiology and drug safety. 2003 Dec; 12(8):687-92.

Srisuriyachanchai W, Cox AR, Kampichit S, Jarernsiripornkul N. Severity and Management of Adverse Drug Reactions Reported by Patients and Healthcare Professionals: A Cross-Sectional Survey. Int J Environ Res Public Health. 2023 Feb 20; 20(4):3725.

Farcas A, Sinpetrean A, Mogosan C, Palage M, Vostinaru O, Bojita M, Dumitrascu D. Adverse drug reactions detected by stimulated spontaneous reporting in an internal medicine department in Romania. Eur J Intern Med. 2010 Oct; 21(5):453-7.

Stroup TS, Gray N. Management of common adverse effects of antipsychotic medications. World Psychiatry. 2018 Oct; 17(3):341-56.

Schulz P, Steimer T. Psychotropic medication, psychiatric disorders, and higher brain functions. Dialogues Clin Neurosci. 2000 Sep; 2(3):177-82.

Cozanitis DA. One hundred years of barbiturates and their saint. J R Soc Med. 2004 Dec; 97(12):594-8.

Bobo WV, More KF. Potential Association Between Risperidone and Cerebrovascular Events. Prim Care Companion J Clin Psychiatry. 2003 Jun; 5(3): 141.

Angelo Antonini, Werner Poewe. Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease. The Lancet Neurology, 2007; 6(9): 826-9.

King, M., Ashraf, N. Tricyclic Antidepressant-Induced Anticholinergic Delirium in a Young Healthy Male Individual. Drug Saf - Case Rep, 2018: 5(1): 1-5.

Ferner R, Pucci M. Adverse drug reactions. Medicine. 2020 Jul; 48(7):443-9.

Griffin CE 3rd, Kaye AM, Bueno FR, Kaye AD. Benzodiazepine pharmacology and central nervous system-mediated effects. Ochsner J. 2013 Summer; 13(2): 214-23.

Simone CG, Bobrin BD. Anxiolytics and Sedative-Hypnotics Toxicity. [Updated 2023 Jan 13]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing.

Kaplan K, Hunsberger HC. Benzodiazepine-induced anterograde amnesia: detrimental side effect to novel study tool. Front Pharmacol. 2023 Sep 14; 14: 1257030.

Simone CG, Bobrin BD. Anxiolytics and Sedative-Hypnotics Toxicity. [Updated 2023 Jan 13]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing.

Coleman JJ, Pontefract SK. Adverse drug reactions. Clin Med (Lond). 2016 Oct;16(5):481-5. doi: 10.7861/clinmedicine.16-5-481.

Sriram S, Ghasemi A, Ramasamy R, Devi M, Balasubramanian R, Ravi TK, Sabzghabaee AM. Prevalence of adverse drug reactions at a private tertiary care hospital in south India. J Res Med Sci. 2011 Jan; 16(1):16-25.

Van Grootheest K, Olsson S, Couper M, de Jong-van den Berg L: Pharmacists’ role in reporting adverse drug reactions in an international perspective. Pharmacoepidemiol Drug Saf. 2004, 3: 457-64.

Baniasadi S, Habibi M, Haghgoo R, Karimi Gamishan M, Dabaghzadeh F, Farasatinasab M, Farsaei S, Gharekhani A, Kafi H, Karimzadeh I, Kharazmkia A, Najmeddin F, Nikvarz N, Oghazian MB, Rezaee H, Sadeghi K, Tafazzoli A, Shahsavari N, Fahimi F. Increasing the number of adverse drug reactions reporting: the role of clinical pharmacy residents. Iran J Pharm Res. 2014 Winter; 13(1): 291-7.

Yawson AA, Abekah-Nkrumah G, Okai GA, Ofori CG. Awareness, knowledge, and attitude toward adverse drug reaction (ADR) reporting among healthcare professionals in Ghana. Ther Adv Drug Saf. 2022 Aug 6; 13: 20420986221116468.

Hamid AAA, Rahim R, Teo SP. Pharmacovigilance and Its Importance for Primary Health Care Professionals. Korean J Fam Med. 2022 Sep; 43(5): 290-5.

Delgado-Pérez G, Dávila-Espinoza C, Beltran-Noblega C. Impact of the Role of the Clinical Pharmacist on the Underreporting of Adverse Drug Reactions at a Peruvian hospital. Hosp Pharm. 2023 Jun; 58(3): 295-303.

Dalton K, Byrne S. Role of the pharmacist in reducing healthcare costs: current insights. Integr Pharm Res Pract. 2017 Jan 25; 6: 37-46.

Published

2024-07-31
Statistics
24 Views | 24 Downloads
Citatons

How to Cite

Srinivasa Rao, V. ., K. . Suresh Kumar, K. . Slesha Kumar, and G. . Santosh Kumar. “Adverse Drug Reactions in Psychiatry: An Alarming Scenario”. Journal of Clinical and Pharmaceutical Research, vol. 4, no. 3, July 2024, pp. 13-16, doi:10.61427/jcpr.v4.i3.2024.130.

Issue

Section

Review Articles